We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Positron Emission Tomography (PET)-Computed Tomography (CT) in Inflammatory Bowel Disease (IBD)

This study has been terminated.
(No Accrual)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00205062
First Posted: September 20, 2005
Last Update Posted: October 5, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of Wisconsin, Madison
September 13, 2005
September 20, 2005
October 5, 2015
October 2004
August 2008   (Final data collection date for primary outcome measure)
Does this technique provide an accurate assessment of disease inflammation compared to standard clinical markers?
Same as current
Complete list of historical versions of study NCT00205062 on ClinicalTrials.gov Archive Site
Does this technique provide additional information for practitioners on extent of disease?
Same as current
Not Provided
Not Provided
 
Positron Emission Tomography (PET)-Computed Tomography (CT) in Inflammatory Bowel Disease (IBD)
Pilot Study of the Role of PET-CT for Diagnosis and Assessment of Therapeutic Efficacy in Inflammatory Bowel Disease
The main hypothesis is that PET-CT will be a valuable diagnostic tool in diagnosing and evaluating treatment for IBD.
Not Provided
Interventional
Phase 4
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Inflammatory Bowel Diseases
Procedure: PET-CT
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
Not Provided
August 2008
August 2008   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patient with either Crohn's disease or ulcerative colitis whose disease is flaring

Exclusion Criteria:

  • Indeterminate diagnosis, pregnant, breastfeeding, or other contraindication to PET-CT
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00205062
M-2004-0251
Not Provided
Not Provided
Not Provided
University of Wisconsin, Madison
University of Wisconsin, Madison
Not Provided
Principal Investigator: Randall Meisner, MD University of Wisconsin, Madison
University of Wisconsin, Madison
September 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP